IL118202A0 - Pharmaceutical administration form of parathyroid hormone having an active ingredient release period of from two to six hours - Google Patents
Pharmaceutical administration form of parathyroid hormone having an active ingredient release period of from two to six hoursInfo
- Publication number
- IL118202A0 IL118202A0 IL11820296A IL11820296A IL118202A0 IL 118202 A0 IL118202 A0 IL 118202A0 IL 11820296 A IL11820296 A IL 11820296A IL 11820296 A IL11820296 A IL 11820296A IL 118202 A0 IL118202 A0 IL 118202A0
- Authority
- IL
- Israel
- Prior art keywords
- hours
- active ingredient
- parathyroid hormone
- administration form
- release period
- Prior art date
Links
- 102000003982 Parathyroid hormone Human genes 0.000 title 1
- 108090000445 Parathyroid hormone Proteins 0.000 title 1
- 239000004480 active ingredient Substances 0.000 title 1
- 239000000199 parathyroid hormone Substances 0.000 title 1
- 229960001319 parathyroid hormone Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Diabetes (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nutrition Science (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19517430A DE19517430A1 (en) | 1995-05-12 | 1995-05-12 | Pharmaceutical dosage form of parathyroid hormone with a two to six hour drug release period |
Publications (1)
Publication Number | Publication Date |
---|---|
IL118202A0 true IL118202A0 (en) | 1996-09-12 |
Family
ID=7761731
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL11820296A IL118202A0 (en) | 1995-05-12 | 1996-05-09 | Pharmaceutical administration form of parathyroid hormone having an active ingredient release period of from two to six hours |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0825872A1 (en) |
JP (1) | JPH11505222A (en) |
AU (1) | AU5816596A (en) |
DE (1) | DE19517430A1 (en) |
IL (1) | IL118202A0 (en) |
WO (1) | WO1996035447A1 (en) |
ZA (1) | ZA963714B (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0922467A3 (en) | 1997-12-12 | 2000-05-24 | Takeda Chemical Industries, Ltd. | Iontophoretic drug delivery |
US8088734B2 (en) | 2003-01-21 | 2012-01-03 | Unigene Laboratories Inc. | Oral delivery of peptides |
US7994129B2 (en) | 2005-11-10 | 2011-08-09 | Michigan Technological University | Methods of using black bear parathyroid hormone |
EP2509996A1 (en) | 2009-12-07 | 2012-10-17 | Michigan Technological University | Black bear parathyroid hormone and methods of using black bear parathyroid hormone |
HUE030072T2 (en) | 2010-05-12 | 2017-04-28 | Radius Health Inc | Therapeutic regimens |
AU2011312490B2 (en) | 2010-09-28 | 2015-06-25 | Radius Pharmaceuticals, Inc. | Selective androgen receptor modulators |
CA2984200C (en) | 2015-04-29 | 2024-03-19 | Radius Pharmaceuticals, Inc. | Combinations of rad1901 and a cdk 4/6 inhibitor for treating cancer |
WO2017223115A1 (en) | 2016-06-22 | 2017-12-28 | Radius Health, Inc. | Ar+ breast cancer treatment methods |
KR20230109795A (en) | 2017-01-05 | 2023-07-20 | 래디어스 파마슈티컬스, 인코포레이티드 | Polymorphic forms of rad1901-2hcl |
SG11202013177WA (en) | 2018-07-04 | 2021-01-28 | Radius Pharmaceuticals Inc | Polymorphic forms of rad 1901-2hcl |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4692433A (en) * | 1983-10-12 | 1987-09-08 | The Regents Of The University Of California | Method and composition for regulating serum calcium levels of mammals |
DE3935738A1 (en) * | 1989-10-27 | 1991-05-08 | Forssmann Wolf Georg | DRUGS CONTAINING THE HUMAN PARATHORMONE FRAGMENT (1-37) AS AN ACTIVE AGENT |
DE69429603T2 (en) * | 1993-09-22 | 2002-08-14 | Hisamitsu Pharmaceutical Co., Inc. | Iontophoresematrix |
-
1995
- 1995-05-12 DE DE19517430A patent/DE19517430A1/en not_active Withdrawn
-
1996
- 1996-05-09 WO PCT/EP1996/001962 patent/WO1996035447A1/en not_active Application Discontinuation
- 1996-05-09 EP EP96919738A patent/EP0825872A1/en not_active Withdrawn
- 1996-05-09 AU AU58165/96A patent/AU5816596A/en not_active Abandoned
- 1996-05-09 JP JP8533762A patent/JPH11505222A/en active Pending
- 1996-05-09 IL IL11820296A patent/IL118202A0/en unknown
- 1996-05-10 ZA ZA9603714A patent/ZA963714B/en unknown
Also Published As
Publication number | Publication date |
---|---|
JPH11505222A (en) | 1999-05-18 |
ZA963714B (en) | 1997-11-10 |
WO1996035447A1 (en) | 1996-11-14 |
DE19517430A1 (en) | 1996-11-14 |
AU5816596A (en) | 1996-11-29 |
EP0825872A1 (en) | 1998-03-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL104192A0 (en) | Pharmaceutical dosage forms having prolonged release rate of active ingredient | |
HUT60466A (en) | Process for producing amino acid derivatives and pharmaceutical compositions comprising such active ingredient | |
HUT59314A (en) | Process for producing pharmaceutical composition comprising minocylcine active ingredient and suitable for a single daily administration | |
HUT64065A (en) | Process for producing quinolone- and naphthyridonecarboxylic acid derivatives and pharmaceutical compositions comprising same as active ingredient | |
GB2143734B (en) | Process for the preparation of sustained release pharmaceutical compositions having a high active ingredient content | |
EP0727217A3 (en) | Pharmaceutical composition containing god-type ellagitannin as active ingredient | |
IL106326A (en) | Analogs of parathyroid hormone, their production and pharmaceutical compositions containing them | |
HUP9901457A3 (en) | Three-phase pharmaceutical form with constant and controlled release of amorphous active ingredient for single daily application | |
HUT51254A (en) | Process for producing amino acid derivatives and pharmaceutical compositions comprising same as active ingredient | |
EP0224146A3 (en) | Pharmaceutical preparation for the controlled release of active ingredients | |
GB8403138D0 (en) | Sustained release of active ingredient | |
DK583789A (en) | SYSTEM FOR TRANSMUCOSAL ADMINISTRATION OF THE ACTIVE INGREDIENT OF A MEDICINE | |
HUP0004383A2 (en) | Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient | |
IL70071A (en) | Multilayered sustained release pharmaceutical tablets having non-uniform distribution of active ingredient | |
HUT49625A (en) | Process for producing macrolid compounds and pharmaceutical compositions comprising such active ingredient | |
HUT58060A (en) | Process for producing amino acid derivatives and pharmaceutical compositions comprising such active ingredient | |
ZA968715B (en) | Stable pharmaceutical forms of administration containing parathyroid hormone. | |
ZA988718B (en) | Drug formulation having controlled release of active compound | |
IL118202A0 (en) | Pharmaceutical administration form of parathyroid hormone having an active ingredient release period of from two to six hours | |
PL332249A1 (en) | Pharmaceutical microspheres of varproinic acid for oral administration | |
NZ244320A (en) | Acylals of imidazole-5-carboxylic acid, preparation and pharmaceutical compositions thereof | |
HUT59319A (en) | Pharmaceutical compositions with controlled release of active ingredient and process for producing same | |
IT1238072B (en) | PHARMACEUTICAL COMPOSITIONS AND DOSAGE FORMS FOR ORAL ADMINISTRATION OF CALCITONIN | |
ZA9610714B (en) | Rapid release tablet comprising tolfenamic acid or a pharmaceutically acceptable salt thereof as active ingredient and a method of preparing such tablet | |
HUT47127A (en) | Process for producing pyrimidine derivatives and pharmaceutical compositions comprising such active ingredient |